188 related articles for article (PubMed ID: 16392725)
1. Dyslipidemia in HIV patients.
Tungsiripat M; Aberg JA
Cleve Clin J Med; 2005 Dec; 72(12):1113-20. PubMed ID: 16392725
[TBL] [Abstract][Full Text] [Related]
2. Coronary heart disease in people infected with HIV.
Malvestutto CD; Aberg JA
Cleve Clin J Med; 2010 Aug; 77(8):547-56. PubMed ID: 20682517
[TBL] [Abstract][Full Text] [Related]
3. Current pharmacotherapy for the treatment of dyslipidemia associated with HIV infection.
Gebhardt A; Fichtenbaum CJ
Expert Opin Pharmacother; 2019 Oct; 20(14):1719-1729. PubMed ID: 31232617
[No Abstract] [Full Text] [Related]
4. Human Immunodeficiency Virus Infection, Antiretroviral Therapy, and Statin: a Clinical Update.
Zanetti HR; Roever L; Gonçalves A; Resende ES
Curr Atheroscler Rep; 2018 Feb; 20(2):9. PubMed ID: 29423787
[TBL] [Abstract][Full Text] [Related]
5. Clinical management considerations for dyslipidemia in HIV-infected individuals.
Kirchner JT
Postgrad Med; 2012 Jan; 124(1):31-40. PubMed ID: 22314112
[TBL] [Abstract][Full Text] [Related]
6. Fenofibrate in the treatment of dyslipidemia associated with HIV infection.
Samineni D; Fichtenbaum CJ
Expert Opin Drug Metab Toxicol; 2010 Aug; 6(8):995-1004. PubMed ID: 20604734
[TBL] [Abstract][Full Text] [Related]
7. Dyslipidemia and lipid management in HIV-infected patients.
Lo J
Curr Opin Endocrinol Diabetes Obes; 2011 Apr; 18(2):144-7. PubMed ID: 21297466
[TBL] [Abstract][Full Text] [Related]
8. Lipid management in patients who have HIV and are receiving HIV therapy.
Aberg JA
Endocrinol Metab Clin North Am; 2009 Mar; 38(1):207-22. PubMed ID: 19217520
[TBL] [Abstract][Full Text] [Related]
9. [Lipid alterations and cardiovascular risk associated with antiretroviral therapy].
Masiá-Canuto M; Bernal-Morell E; Gutiérrez-Rodero F
Enferm Infecc Microbiol Clin; 2006 Dec; 24(10):637-48. PubMed ID: 17194390
[TBL] [Abstract][Full Text] [Related]
10. Management of lipid disorders in patients living with HIV.
Myerson M; Malvestutto C; Aberg JA
J Clin Pharmacol; 2015 Sep; 55(9):957-74. PubMed ID: 25651539
[TBL] [Abstract][Full Text] [Related]
11. The role of statins in the setting of HIV infection.
Eckard AR; McComsey GA
Curr HIV/AIDS Rep; 2015 Sep; 12(3):305-12. PubMed ID: 26126687
[TBL] [Abstract][Full Text] [Related]
12. Lipid management in human immunodeficiency virus.
Myerson M
Cardiol Clin; 2015 May; 33(2):277-98. PubMed ID: 25939300
[TBL] [Abstract][Full Text] [Related]
13. Response to newly prescribed lipid-lowering therapy in patients with and without HIV infection.
Silverberg MJ; Leyden W; Hurley L; Go AS; Quesenberry CP; Klein D; Horberg MA
Ann Intern Med; 2009 Mar; 150(5):301-13. PubMed ID: 19258558
[TBL] [Abstract][Full Text] [Related]
14. Dyslipidemia in HIV-infected individuals.
Sprinz E; Lazzaretti RK; Kuhmmer R; Ribeiro JP
Braz J Infect Dis; 2010; 14(6):575-88. PubMed ID: 21340298
[TBL] [Abstract][Full Text] [Related]
15. Summaries for patients. Response to cholesterol-lowering drugs in patients with and without HIV infection.
Ann Intern Med; 2009 Mar; 150(5):I38. PubMed ID: 19258553
[No Abstract] [Full Text] [Related]
16. A multimodal, evidence-based approach to achieve lipid targets in the treatment of antiretroviral-associated dyslipidemia: case report and review of the literature.
Bain AM; White EA; Rutherford WS; Rahman AP; Busti AJ
Pharmacotherapy; 2008 Jul; 28(7):932-8. PubMed ID: 18576908
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular risk and dyslipidemia management in HIV-infected patients.
Stein JH
Top Antivir Med; 2012; 20(4):129-33; quiz 123-4. PubMed ID: 23154252
[TBL] [Abstract][Full Text] [Related]
18. Human immunodeficiency virus and renal transplantation.
Dinavahi RV; Mehrotra A; Murphy BT; Huprikar S
Kidney Int; 2009 Oct; 76(8):907-10. PubMed ID: 19494802
[No Abstract] [Full Text] [Related]
19. Prevalence, treatment, and control of dyslipidemia and hypertension in 4278 HIV outpatients.
Myerson M; Poltavskiy E; Armstrong EJ; Kim S; Sharp V; Bang H
J Acquir Immune Defic Syndr; 2014 Aug; 66(4):370-7. PubMed ID: 24732872
[TBL] [Abstract][Full Text] [Related]
20. Effect of chocolate and mate tea on the lipid profile of individuals with HIV/AIDS on antiretroviral therapy: A clinical trial.
Souza SJ; Petrilli AA; Teixeira AM; Pontilho PM; Carioca AA; Luzia LA; Souza JM; Damasceno NR; Segurado AA; Rondó PH
Nutrition; 2017; 43-44():61-68. PubMed ID: 28935146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
